Rare association of ovarian implantation site for patients with heterotopic and with primary ectopic pregnancies after ICSI and blastocyst transfer
- Resource Type
- Authors
- Roger Abdelmassih; S. Abdelmassih; V. Abdelmassih; Jose P. Balmaceda; André Luiz Eigenheer Costa; Flavio G. Oliveira
- Source
- Human Reproduction. 16:2227-2229
- Subject
- Adult
Male
medicine.medical_specialty
medicine.medical_treatment
Intracytoplasmic sperm injection
Pregnancy
medicine
Humans
Embryo Implantation
Sperm Injections, Intracytoplasmic
Blastocyst
Laparoscopy
Gynecology
Labor, Obstetric
medicine.diagnostic_test
Ectopic pregnancy
business.industry
Obstetrics
Rehabilitation
Blastocyst Transfer
Infant, Newborn
Obstetrics and Gynecology
Embryo Transfer
medicine.disease
Embryo transfer
Pregnancy, Ectopic
medicine.anatomical_structure
Reproductive Medicine
Female
Pregnancy, Multiple
business
Ovarian Implantation
- Language
- ISSN
- 1460-2350
0268-1161
Two cases of patients with ruptured ovarian pregnancies (P1 = ovarian heterotopic and P2 = primary ovarian ectopic) after intracytoplasmic sperm injection and blastocyst transfer are presented. Laparoscopy was performed on day 40 and day 27 after transfer in cases P1 and P2 respectively. In both cases the ectopic pregnancies were located on the left ovary and were successfully removed by laparoscopy preserving the ovaries. In case P1 the intrauterine pregnancy was not affected. A healthy boy was born after 37 weeks of pregnancy. In this way, potential fertility of the patients and the intrauterine pregnancy were maintained. These cases occurred during a series of blastocyst transfers in which 129 pregnancies were obtained. There were no cases of ovarian ectopic/heterotopic pregnancies from January 1996 to September 1999 in 814 pregnancies obtained from day 2 or day 3 embryo transfers. Because the ovarian ectopic pregnancies occurred in patients with day 5 embryo transfer who otherwise did not have any predisposing factors for ectopic pregnancy, it is advisable to conduct a large scale analysis of future data about the possible association between blastocyst-stage embryo transfer and the somewhat higher risk of unexpected complications of clinical outcome.